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Abstract 
This report documents phorbol ester (TPA)-
induced changes in cell morphology, and in vitro 
growth patterns in 9 patients with hairy cell 
leukemia (HCL), 21 with B-type CLL and non-
Hodgkin's lymphoma in leukemic phase (NHL), and 10 
with acute non lymphoblastic leukemia (ANLL). TPA 
caused cells from HCL to adhere strongly and 
produce elongated cytoplasmic extensions. Many of 
these cells had an appearance resembling fibroblasts, 
while others showed marked surface ruffling and 
spreading containing increased dense bodies, and 
phagolysosomal vacuoles as seen by transmission 
electron microscopy. 
This HCL in vitro growth pattern after TPA 
exposure differed from that seen in B-CLL and NHL 
cells, which only adhered moderately after 72 hours 
and readily detached in clumps. CLL and NHL-cells 
did not show ultrastructural features of macrophages 
but had either plasmacytic or HCL features. It is 
suggested that these different growth patterns may 
aid in distinguishing HCL from other B-cell 
neoplasias. 
The expression of surface markers, tartrate 
resistant acid phosphatase (TRAP) and lg secretion 
were studied in some B-CLL, NHL and HCL cells 
after exposure to different concentrations of TPA for 
up to 6 days. Results showed that the documented 
changes were frequently both dose and time 
dependent and the most striking HCL-features were 
encountered after 6 days incubation with higher 
concentrations of TPA. However, individual variation 
from case to case was noted. Nevertheless, it seems 
that TPA induces neoplastic B-cells to mature into 
secreting plasmacytoid lymphocytes, and cells with 
features of HCL with variable expression of surface 
markers and TRAP. 
KEY WORDS: Phorbol esters, B-lymphocytic Leuke-
mia, Hairy cell leukemia, B-cells, Lymphocytic 
leukemia, Surface membrane, glycoprotein-70. 
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Introduction 
The phorbol ester TPA is an active modulator 
of differentiation of both lymphoid and myelogenous 
leukemic cells (4,5,17-20,23,24,28,31-33,35). Cells 
isolated from patients with acute non-lymphoblastic 
leukemia (ANLL) have been shown to differentiate 
after in vitro exposure to TPA and mature into 
adherent macrophages (17-20,23,31). In some cases, 
TPA has also been shown to induce non-B non-T 
acute lymphoblastic leukemia (ALL) cells along the 
pathway of maturation towards a more mature T or B 
cell phenotype (4,5,24,32,33). 
In recent years TPA has also been shown to 
induce changes in shape, morphology and membrane 
antigenic components in B-type chronic lymphocytic 
leukemia (CLL) (3,7 ,8,26-28,35). Antigenic and 
functional alterations are reflected in the expression 
of surface markers which appear to be accompanied 
by the production of intracytoplasmic µ chain and 
IgM secretion (3,7 ,26-28,35), Furthermore, there is 
also an increased ability of CLL cells to stimulate in 
a mixed lymphocyte reaction (MLR) (26,27). Thus it 
seems that TPA alters the expression of a variety of 
cellular enzymes and surface markers in a coherent 
fashion and may also induce neoplastic B-cells to 
mature. In some of these studies (3,7,8,26-28,35) B-
CLL cells developed plasmacytoid (28,35) and "hairy" 
cell features (3) and in some instances cells produced 
acid hydrolases which characterize plasma cells and 
other more mature B-c ell neopl asias ( 8). 
Furthermore other studies have shown that cells 
obtained from patients with hairy cell leukemia 
(HCL) may also alter their shape and surface 
membrane after in vitro exposure to TPA, in a 
manner different to B-CLL (21,22,30). 
The present study was performed in order to 
(1) further characterise the changes induced by TPA 
in a variety of leukemic cell types, and (2) correlate 
alterations in cell surface topography with changes 
in surface marker phenotype induced by phorbol 
esters. In particular, B-cells were obtained from 
patients with HCL, CLL and NHL in leukemic phase 
and compared with special emphasis on ultrastructure 
surface features, expression of surface membrane 
immunoglobulin(Ig) and the novel B-cell marker, GP-
70 (10-13), the induction of tartrate resistant acid 
phosphatase (TRAP) and lg secretion. Efforts were 
also made to define the nature of the "hairy" cell 
features induced in B-CLL and NHL cells after 
exposure to TPA and to determine whether these 
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changes were in any way dependent on the 
concentration of TPA or the length of in vitro 
incubation. In addition, some of the data obtained 
for B-CLL and NHL are contrasted with those 
obtained in cells isolated from patients with HCL and 
ANLL. 
Materials and Methods 
Clinical data 
Nme cases of HCL, 16 with CLL, 5 with NHL in 
leukemic phase and 10 with ANLL were included in 
this study. All cases were diagnosed according to 
well established hematological criteria (36). 
HCL: All 9 cases had the typical features 
outlined by Golomb (15), with 10 to 50% hairy cells 
in the peripheral blood. Two of the 9 cases had no 
palpable splenomegaly, however typical findings were 
found on bone marrow biopsy in all patients 
examined after splenectomy. Hairy cells were first 
identified by phase microscopy and in all cases TRAP 
was present in a varying proportion of cells. In all 
cases surface membrane immunoglobulin ( Sm!g) and 
GP -7 0 antigen were readily detected by 
immunofluorescence and relatively low numbers of 
MRBC-rosetting cells were seen. 
CLL and NHL: Only typical cases of B-CLL and 
NHL m leukemic phase were included in this study 
(29). All cases had more than 15,000/mm3 leukocytes 
in the peripheral blood with more than 80% lymphoid 
cells. All cases showed positive immunofluorescence 
for Smlg. CLL cells usually showed faint or 
moderate positivity while NHL cells showed bright 
staining. In all cases Ia receptors and GP-70 antigen 
were present. 
ANLL: All 10 cases had high WBC counts 
( > 25-;oITTi7mm3) with typical morphology. Cyto-
chemical stains for myeloperoxidase, sudan black, 
muramidase, acid phosphatase and non -specific 
esterases (29) invariably showed large numbers of 
diffusely positive cells. · 
Cell Suspensions: In general, cells were 
isolated from the peripheral blood. In addition cells 
were also isolated from the spleens of 2 
splenectomized HCL patients. Mononuclear cells 
were concentrated using the Ficoll-Hypaque gradient 
centrifugation technique (1), washed twice and 
resuspended in RPMI-1640 medium supplemented with 
10% heat-inactivated foetal calf serum (Grand Island 
Biological Co., Grand Island, New York). 
Electron Microscopy 
TEM: Cells were fixed with 2% glutaraldehyde 
in phosphate buffer after initial washing with 
phosphate buffered saline (PBS). Cells were then 
postfixed in 2% osmium tetroxide, dehydrated and 
embedded in low viscosity epoxy resin (Polaron Ltd., 
England) (34) and sectioned using an MT-2 Porter 
Blum microtome and a diamond knife. Thin sections 
were mounted on copper grids, double stained with 
uranyl acetate and lead citrate, and viewed with a 
Philips E M-300 transmission electron microscope at 
an accelerating voltage of 40-60 kV. 
SE M: Cells were initially fixed in suspension 
with f%glutaraldehyde in PBS for at least one hour. 
Thereafter cells were prepared for SEM using the 
GTGO procedure as described in detail in an earlier 
study (9). This method involves glutaraldehyde 
fixation followed by tannic acid (T)-guanidine 
hydrochloride (G) treatment of the cells and 
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subsequent immersion in osmium tetroxide (0) 
solution. The GTGO procedure results in excellent 
cell surface preservation and allows for easy air 
drying with less shrinkage than the critical point 
drying procedure (9). The air dried specimens were 
then coated by a low discharge with a thin layer of 
gold palladium and examined with a JEOL JSM-35 
SEM at an accelerating voltage of 25-39 kV. 
Incubation with TPA: 2 ml cell suspensions 
containing 2 x 106 cells/ml, were incubated in tissue 
culture dishes ( 35 mm diameter, Nunc, Denmark) with 
TPA (Sigma Chemical Co., St. Louis, Mo, USA) at a 
final concentration of 1, 10, 100 ng / ml. Duplicate 
petri dishes were incubated at 37°C in a 5% CO2 
humidified atmosphere for up to 6 days. Cells were 
then inspected with an inverted microscope and 
harvested at days 1, 2, 3, and 6. Adherence was 
readily visible using the inverted light microscope. 
Non-adherent cells readily dislodged by gentle 
shaking floated off the dishes into the supernatant 
and were detected as clumps. Both adherent and 
non-adherent cells were collected either directly 
from the medium or with a rubber policeman on days 
1, 2, 3 and 6. 
Surface Markers: For surface marker studies, 
cells were collected and washed three times with 
phosphate buffered saline and stained for surface 
membrane immunoglobulin (Smlg) with anti human lg 
and for GP-70 with anti GP-70 antibody as described 
in earlier studies (10-13). Stained cells were scored 
by fluorescence microscopy and by the fluorescent 
activated cell sorter (FACS, 440 Becton Dickinson, 
USA). Culture medium was also collected and 
samples of 100 µl were used for determination of lg 
secretion by micro Elisa test as described before 
(14). Briefly, aliquots of 0.1 ml of culture 
supernatant were placed in triplicate wells of an anti 
human lg coated microtiter plate (Nunc, Denmark 
micro Elisa plate). Anti human lg conjugated to 
alkaline phosphatase was used for detection of bound 
lg (Sigma, St. Louis, MO, USA). Purified IgG (Miles 
Laboratories Inc., USA) was used as a standard for 
quantitation. 
Cytochemistry: Staining for myeloperoxidase, 
sudan black, esterases, acid phosphatase and 
muramidase in leukemic cells was performed in ANLL 
cells prior to incubation as described in earlier 
studies (28,29) while TRAP staining was done 
according to Yam et al. (37). 
Results 
Scanning electron microscopy 
CLL and NHL: Cells from all cases examined 
prior to TPA exposure were spherical with varying 
numbers of short finger-like microvilli (Figure 1). 
B-NHL cells generally showed more microvilli than B-
CLL cells. Control lymphocytes after incubation for 
72 h were rarely adherent, generally lacked microvilli 
and many underwent necrosis. 
After TPA exposure for up to 72 h B-CLL and 
NHL cells from all cases were minimally adherent, 
forming only small clumps or aggregates (Figure 2) 
which were readily dislodged from the substrate 
(Figure 3). After 72 h incubation with TPA, cells 
tended to lose their characteristic microvilli. 
Furthermore cells appeared less spherical in shape, 
with some ruffles at the periphery (Figure 4). 
Transmission electron microscopy showed that many 
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Figure 1. Spherical B-CLL cells with multiple surface 
microvilli. 
Figure 2. Small numbers of B-CLL cells attached to 
the substrate after 72 h exposure to TPA. 
Figure 3. Clumps of TPA-exposed B-CLL cells 
collected from the supernatant medium showing 
scattered microvilli and polarized ruffles. 
Figure 4. Higher magnification of a clump of B-CLL 
cells collected from the supernatant medium after 
incubation with TPA for 72 h. Polarized peripheral 





Close up of two hairy cells prior to 
with TPA, showing typical surface 
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Table 1 







Non-Adherent Elongated TEM and SEM 
Findings Clumps "Fibroblast-like" 
CLL & NHL 21 1 21 
HCL 9 9 0 
ANLL 10 10 0 
of these cells had more irregular surfaces and had 
developed an increase in the amount of rough 
endoplasmic reticulum as seen in secreting B-cells 
and plasma cells and as described in earlier studies 
(28,35). No ribosomal-lamellar complexes were seen. 
HCL: Prior to incubation with TPA, HCL cells 
displayed the typical surface features described in 
earlier SE M studies (16). Cells showed the presence 
of prominent ruffles with clusters of microvilli 
scattered in between the ruffles (Figure 5). Other 
HCL cells showed multiple microvilli with smaller 
numbers of ruffles. After incubation with TPA for 
72 h, HCL cells became markedly adherent and did 
not detach after vigorous shaking ( Figures 6, 7) . In 
all cases HCL cells underwent gross shape changes 
and long thin cytoplasmic processes and filopodia, 
which were frequently branched, became evident. 
These cytoplasmic processes reached up to 10 times 
the cell diameter (Figure 8). Many of the cells 
showed extensive surface ruffled folds (Figure 9). 
Occasionally TPA-treated cells retained their 
spherical shape and surface features after adherence, 
however control cells were rarely seen on the 
underlying substrate after 72 h but when present 
they appeared to retain their spherical shape and 
typical surface features. The thin elongated 
filopodia and spreading "macrophage" appearance 
were not seen. 
Transmission electron microscopy showed that 
TPA exposed HCL cells showed more features of the 
macrophage cell series than TPA-exposed B-CLL and 
NHL cells. The plasmacytic features so typical for 
the latter were not evident in TPA treated hairy 
cells. TPA-exposed HCL cells had markedly irregular 
surfaces and elongated cytoplasmic extensions. 
Sometimes containing ribosomal-lamellar complexes, 
were seen (Figure 10). These HCL cells had much 
more abundant cytoplasm which contained more dense 
bodies, vesicles and phagolysosomes than HCL cells 
unexposed to TPA (Figure 11). 
ANLL: In all cases the dominant cell type in 
the peripheral blood, prior to incubation with TPA, 
showed ridge-like folds and ruffles covering the 
entire cell surface (Figure 12) as described in detail 
in earlier studies (28). Control cells cultured 
without TPA rarely formed adherent colonies and 
only isolated cells spread out onto the substrate and 
became adherent. In all TPA exposed cultures there 
was striking adherence of the cells to the underlying 
1 Plasmacytic and 
hairy cell features 
9 No plasmacytic features. 
Adherent cells with 
ruffles 
1 Spreading adherent macro-
Occasional cells phages with ruffles (28). 
substrate and vigorous shaking did not result in cell 
detachment. Confluent overlapping colonies of cells 
were sometimes seen as described for myelomonocytic 
leukemias in an earlier study (28). Cells spread out 
onto the substrate and became flattened with marked 
ruffling of their surfaces (Figures 13, 14). Despite 
the fact that some of these adherent cells resembled 
TPA-treated HCL colonies in culture, "fibroblast" -like 
cells with elongated thin cytoplasmic extensions were 
noted in only one case (Figure 14). In this respect 
they were very different from HCL cells. TEM 
confirmed these observations and showed that the 
majority of adherent TPA-treated monoblasts were in 
fact macrophages containing many dense bodies, 
vacuoles and phagolysosomes as described in an 
earlier study (28). 
In summary (Table 1) 72 h TPA-treated HCL 
cultures were distinctly different from those observed 
in B-CLL and NHL cells, despite the fact that HCL 
cells are also B-derived neoplasias. The elongated 
"fibroblast"-like appearance of the cultures TPA-
exposed HCL cells was not seen in B-CLL and NHL 
and was only rarely evident in ANLL cultures 
exposed to TPA. 
6 day B-CLL and NHL cultures: B-NHL and 
CLL cultures examined after 6 days exposure to TPA, 
showed a different growth pattern than that 
Figures 6, 7. Low magnification of adherent hairy 
cells after 72 h incubation with TPA. Cell cultures 
are overlapping. Many thin elongated cytoplasmic 
extensions are seen. + 
Figure 8. Typical example of single hairy cells with 
fibroblast-like appearance after TPA exposure. The 
cells show thin elongated cytoplasmic extensions, 
some of which are branching. 
Figure 9. TPA-exposed hairy cells showing prominent 
surface ruffles. 
Figures 10, 11. TEM of TPA-exposed hairy cells: 
Close up of cytoplasm of TPA-exposed hairy cell 
showing ribosomal-lamellar complex (Figure 10); 
Figure 11 shows a TPA-treated hairy cell with 
abundant cytoplasm, showing multiple vesicles. 
7526 
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Figure 12. Leukemic monoblasts prior to incubation 
with TPA showing prominent transverse folds and 
ruffles. 
Figures 13, 14. TPA-exposed monoblast cultures, 
Figure 13 shows adherent spreading monocytic cell 
cultures with prominent surface ruffles (x 3200). 
Figure 14 illustrates an adherent culture with some 
of the cells showing elongated cytoplasmic extensions 
resembling those seen in HCL. 
Figure 15. Low magnification showing adherence and 
larger clumps of B-CLL cells after 6 days culture 
with TPA. 
Figure 16. Higher magnification of B-CLL cells 
spreading onto substrate with the development of 
prominent ruffles and hairy cell-like appearance after 
6 days incubation with TPA. 
1528 
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Figures 17, 18. 6 day TPA-cultures B-CLL cells 
showing shape/change, hairy cell-like appearance and 
more prominent adherence onto substrate than that 
seen after 72 h. 
observed after 48-72 h. Cells adhered more markedly 
to the substrate and larger clumps were seen (Figure 
15) while individual cells within these clumps spread 
impressively and developed prominent ruffles (Figure 
16). Cells frequently developed both ruffles and 
small clusters of microvilli, resembling HCL cells 
(Figure 17), while others became elongated and 
irregular with cytoplasmic extensions (Figure 18). 
These late "hairy" cell features were more evident 
after incubation with the higher concentrations of 
TPA (10 ng and 100 ng TPA/cc) and less prominent 
after 1 ng/cc of TPA. They were most impressive 
after 6 days culture and rarely seen until day 6. 
Heterogeneity of cell response was noted from 
patient to patient and in individual cases no 
differences between 1 ng, 10 ng and 100 ng TPA/ml 
was noted while in others, marked morphological 
~ 
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Figures 19a & b. Distribution of Smlg (a) and GP-70 
(b) in CLL cells (patient No. 9 in Table 2), following 
incubation with TPA. Cells were cultured and 
stained for surface markers as described in Materials 
and Methods section. Cells were cultured with 1 
ng/cc of TPA (-); 10 ng/cc (---) and 100 ng/cc 
(--) of TPA. Cell fluorescence analysis and % 
positive cells were obtained by counting 30,000 cells 
in FACS (Becton Dickinson, 440) at 600 V and x 4 
fluorescence amplification. 
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changes were evident after both concentrations were 
used, even after short incubation periods of 24-48 h. 
Plasmacytoid transformation of cells was more 
striking after cells were incubated for 48-72 h with 
TPA while "hairy" cell features were more prominent 
after 6 days incubation with TPA. Thus it seems 
that the in vitro morphological changes seen in this 
study were both time and dose dependent, a 
phenomenon which is also discussed in relation to 
changes in TRAP staining and surface markers. 
Surface markers, lg secretion and cytochemical 
changes in TRAP 
Eleven CLL, 7 NHL, 5 HCL patients and 4 
healthy individuals were included in this part of the 
study (Table 2). Mononuclear cells concentrated 
after gradient centrifugation were incubated with low 
dose (1 ng/ml), intermediate dose (10 ng/ml) and 
high dose (100 ng/ml) of TPA for up to 6 days. 
Cells were examined on days 1, 2, 3 and 6 for lg 
secretion, expression of Smlg and GP-70 and for 
TRAP positivity. 
CLL: In general, the extent of alterations 
recorded after TPA depended on the dose and 
duration of exposure to TPA. Thus, as illustrated in 
Figure 19, 24 h exposure to TPA induced a slight 
initial decrease in the expression of both surface 
A. Polliack, et al. 
Table 2 
TPA-INDUCED ALTERATIONS IN THE EXPRESSION OF SURFACE MEMBRANE MARKERS, 
TRAP AND lg SECRETION IN CHRONIC LYMPHOCYTIC LEUKEMIA 
(AFTER 6 DAYS CULTURE USING 100 ng/cc TPA) 
Patient Surface 
number Smlg (%) 
-TPA +TPA 
1 60 30 
2 5 25 
3 40 60 
4 35 5 
5 55 20 
6 5 60 
7 25 45 
8 25 10 
9 60 10 
10 20 0 
11 20 0 






































*1ess than 50 ng/ml (-); greater than 50 -100 ng/ml (+); greater than 100 - less than 500 ng/ml (++); greater 
than 500 ng/ml (+++). 
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Figure ZO. TPA-induced lg secretion in CLL cells. 
Cell culture (patient No. 9 in Table 2) and measure-
ment of lg secretion were performed as described in 
the Materials and Methods section. Cells were 
cultured with 1 ng/cc of TPA (-), 10 ng/cc (---) and 
100 ng/cc (-) of TPA. 
markers followed by a transient increase at day 4 
and subsequent decrease at day 6 when the level of 
expression of GP-70 and Smlg was at its lowest. On 
the other hand lg secretion (Figure 20) and the 
proportion of TRAP positive cells (Figure 21) showed 
a more convincing time and dose dependency for 
TP A. However, in general as with the surface 
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DAYS IN CULTURE 
Figure 21. TPA-induced acid phosphatase in CLL 
cells. Cell culture (patient number 9 in Table 2). 
11 acid phosphatase, ■ tartrate resistant acid 
phosphatase (TRAP). Cells were cultured with 1 ng, 
10 ng and 100 ng/cc of TPA for 6 days (do = day 
zero; d2 = day 2; d4 = day 4; d5 = day 6). 
TPA was also noted in relation to lg secretion and 
surface marker expression as illustrated in Table 2. 
From this table it is evident that both Smlg and GP-
70 expression before TPA treatment was highly 
heterogeneous which could explain why in some cases 
CLL cells reacted to TPA with increased expression 
of surface markers while others responded in the 
reverse fashion. lg secretion was also heterogeneous 
and in less than half of the patients, the cells 
secreted lg following TPA treatment while in the 
rest no increase was detected. In contrast to these 
1530 
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Table 3 
TPA-INDUCED ALTERATIONS IN THE EXPRESSION OF SURFACE MEMBRANE MARKERS 
TRAP AND lg SECRETION IN NHL, HCL AND CONTROL LYMPHOCYTES ' 
(AFTER 6 DAYS CULTURE USING 10 ng/cc TPA) 
Type of 
Leukemia 
Pt. No. Sm lg(%) GP-70 (%) TRAP (%) lg 
Secretion* -TPA +TPA -TPA +TPA -TPA +TPA 
NHL 1 0 10 0 5 0 5 
( in remission) 2 6 60 0 10 0 8 
3 12 65 0 0 0 30 
Mean +SD 9(+6) 14(+13) 
NHL (in partial 4 0 60 0 30 0 48 + 
remission or 5 15 60 4 50 0 65 + 
active disease) 6 35 13 20 12 0 52 + 
7 40 60 20 30 0 25 +++ 
Mean +SD 22.5(+18) 11(!._10) 47(+16) 
HCL 1 5 12 6 11 5 39 
2 10 65 6 0 2 10 ++ 
3 5 60 6 65 6 12 +++ 
4 5 35 0 25 10 12 +++ 
5 0 10 0 5 ND ND +++ 
Mean +SD 5(+3.5) 3.6(+3) 5.8(+3) 18.3(+4) 
Normal 1 18 0 4 0 0 20 + 
2 20 0 3 0 0 18 + 
3 19 26 11 19 0 10 + 
4 25 12 5 6 0 10 + 
Mean +SD 20(+3) 6(+3) 15(+5) 
*less than 50 ng/ml (-); greater than 50-100 ng/ml (+); less than 500 ng/ml (++); greater than 500 ng/ml (+++). 
ND = not detected 
findings, an impressive increase in TRAP positive 
cells was observed in all cases tested, although in 
almost all instances, varying numbers of TRAP 
negative cells were also found (Table 2). 
NHL: Cells from seven NHL patients were 
examined. These patients were in complete remission 
(CR), partial remission (PR) or with active leukemic 
phase in the peripheral blood. Prior to TP A 
exposure the expression of surface membrane lg, GP-
70, TRAP and lg secretion were very low in cells 
obtained from patients with NHL in CR. Cells 
derived from patients with NHL in PR and with 
active diseases showed more expression of surface lg 
and GP-70 but were essentially TRAP negative. 
Following TPA exposure a moderate increase in lg 
secretion, expression of surface lg and GP -7 0 and 
TRAP positivity was noted in cells from patients 
with CR while in cases of PR or active disease a 
greater increase in the expression of surface lg and 
particularly GP-70 was noted while TRAP positivity 
and lg secretion were also increased, (see Table 3). 
HCL: In the five instances of HCL with 
relatively low numbers of hairy cells in the 
peripheral blood the expression of surface membrane 
lg, GP-70, TRAP positivity and lg secretion was 
relatively low but an increase in all these parameters 
occurred following exposure to TPA. 
Normal lymphocytes: Prior to TPA treatment 
normal peripheral blood lymphocytes had relatively 
low expression of surface membrane lg and GP-70 
while TRAP positivity was close to zero. After TPA 
exposure, only the level of TRAP positivity increased 
to a mean of about 15% with a mild increase in lg 
secretion. GP-70 and surface lg expression were not 
increased in the normal cells. 
Discussion 
Impressive and consistent changes in 
morphology and cell shape were observed in HCL 
after cells were exposed to the phorbol ester TPA. 
After TPA exposure hairy cells became very adherent 
to the underlying substrate, and were not dislodged 
by vigorous shaking. Cells produced extremely long 
narrow cytoplasmic extensions which were evident in 
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all cases. These adherent cells developed surface 
ruffles, resembled macrophages and fibroblasts, and 
spread onto the substrate forming confluent cultures. 
Transmission electron microscopic features were 
reminiscent of the macrophage cell series, however, 
cells retained their ribosomal lamellar complexes 
which are regarded as typical for HCL (6), despite 
their elongated fibroblast-like appearance. Similar 
findings were reported by Lockney et al. (21) who 
also described a unique cell surface glycoprotein 
expression in HCL. Despite the fact that hairy cells 
are known to be B-lymphocyte derived they did not 
develop plasmacytoid features after TPA exposure, as 
in other B-cell disorders. On the contrary, TPA 
appeared to enhance the adherent and phagocytic 
properties evident in HCL cells under normal 
conditions (6), while other B-cell characteristics such 
as lg secretion were not affected. Despite the fact 
that CLL and NHL cells are also B-derived their in 
vitro growth response to TP A was very different. 
B-CLL and NHL cells showed minimal adherence onto 
the substrate after TPA exposure but did not form 
spreading monolayers. Cells appeared to form small 
clumps and were readily detached into the 
supernatant. Furthermore, they did not develop 
ultrastructural features of macrophages or fibroblasts 
but many acquired hairy cell and plasmacytoid 
features. 
It is of interest to note that in general HCL 
cells showed a different pattern of cell growth than 
myelo-monocytic leukemic cells exposed to TPA. The 
elongated cytoplasmic filopodia and fibroblast 
appearance encountered in HCL were seldom seem in 
leukemic monomyeloblasts despite the fact that both 
cell types showed extensive ruffling of their surfaces 
and marked adhesion to the substrate, properties 
which are both regarded as characteristic for 
macrophages. The dramatic morphological changes 
induced in HCL cells by TPA appear to be specific 
for this leukemic cell type and some authors (21,22) 
have suggested that they are due to changes in the 
non-glycosylated cytoskeletal components. In the 
light of the in vitro growth patterns observed for 
HCL, which are distinctly different to those 
encountered in B-CLL and NHL, we continue to 
recommend that short term culture and exposure to 
TPA be added to the diagnostic laboratory tests 
currently employed in the differential diagnosis of 
HCL and other B-cell neoplasias. This laboratory 
test may be particularly useful to distinguish HCL 
from other B-type lymphoid neoplasias which may at 
times show clinical and cytological features 
mimicking HCL (2,25). 
Other interesting aspects of this study relate to 
the apparent time and dose dependency in response 
to TPA in cases of B-CLL and NHL. The maximum 
expression of surface membrane marker alterations 
appears to occur after 6 days incubation and after 
higher concentrations of TPA. Thus TPA induces 
non-secreting B-cells to evolve into transformed 
lymphoblasts, secreting plasmacytoid cells, and plasma 
cells with eventual evolution into cells with features 
seen in hairy cell leukemia. The latter include the 
appearance of TRAP positivity in a high proportion 
of cells and surface features similar to those 
encountered in HCL. The above features were most 
prominent after 6 days incubation and 100 ng/cc TPA 
and less obvious after 72 h incubation and lower 
concentrations of TPA. Another interesting aspect 
was the variability expressed in almost all tested 
parameters in the different cases. This 
heterogeneity in response to TPA was also evident in 
the expression of Smlg and GP-70, cytoplasmic lg 
secretion, and TRAP positivity as well as in surface 
morphology, as seen by SEM. This heterogeneity was 
already noted in the B-CLL and NHL cells prior to 
incubation with TPA and was more apparent after 
TPA exposure. Furthermore there appeared to be 
little correlation in the expression of the different 
cytological and immunological features regarded as 
characteristic for HCL, e.g., typical adherent hairy 
cells with characteristic surface features after TPA 
were TRAP negative with minimal expression of Smlg 
and GP-70, while in others the reverse was found. 
Thus it seems that differentiating agents like TPA 
are able to induce B-CLL and NHL cells to mature 
along the pathway of secreting B cells towards hairy 
cells. This pathway includes the development of 
secreting plasmacytoid lymphocytes, plasma cells and 
eventually cells with some of the features seem in 
HCL. 
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Discussion with Reviewers 
D. Dantchev: Did you study the morphological and 
other surface changes of T-cells exposed to TPA in 
the same experimental conditions and particularly of 
OKT4+ and OKT8+ cells? 
Authors: In this study we have no data concerning 
OKT4+ and OKT8+ cells derived from the patient 
group described. However, recently we have started 
to follow T cell surface markers expression in TPA-
treated B-CLL mononuclear cell suspensions. As yet 
we have noted no substantial differences in the 
expression of these markers in the cases examined. 
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We have no information about the morphological 
changes in these cells, however in all control 
cultures exposed to TPA in vitro, the dominant cell 
types were T-lymphocytes and in these cases no 
outstanding findings were noted. 
D. Dantchev: After incubation of HCL cells with 
TPA for 72 h you observed in all 9 cases studied 
elongated cells with features of cultured macrophages 
and fibroblasts (Fig. 8), and also other cells 
producing extensive surface ruffled folds (Fig. 9): Is 
it the same population of pathological hairy cells or 
two different populations? Your cases of HCL 
present only 10 to 50% hairy cells: What is the 
nature of the other mononuclear cells? 
Authors: This is indeed an important question to 
answer because of the difficulty in obtaining cases of 
hairy cell leukemia with a pure population of hairy 
cells in the peripheral blood. Thus one has to work 
with a mixed hairy cell and undefined lymphocytic 
population in these cases. However when we 
subsequently used hairy cell leukemia cell 
preparations concentrated from the spleens of 
splenectomized patients containing more than 80% 
hairy cells or cultured hairy cell lines, the same 
pattern of changes emerged which provides indirect 
evidence that the SEM changes described in this 
study are indeed those occurring in hairy cells and 
not in other mononuclear cells. 
D. Dantchev: There is a high heterogeneity in 
response to TPA, expressed in the different 
parameters tested in 11 cases of CLL (Table 2): Is it 
the same in HCL, NHL, and ANLL? 
Authors: As opposed to the heterogeneity seen in B-
type CLL cells exposed to TPA, cells derived from 
patients with HCL, NHL in leukemic phase and ANLL 
showed consistent morphological and surface marker 
changes without much heterogeneity. Markers on 
ANLL cells were not assessed using monoclonal 
antibodies. 
D. Soligo: Do the authors have any experience with 
short term cultures and TPA exposure in 
undifferentiated leukemias or in poorly differentiated 
ANLL? Is there a diagnostic role for your 
methodology? 
Authors: As the reviewer knows from his own 
chn1cal experience, cases of undifferentiated leukemia 
are extremely rarely obtained in clinical practice. 
Over the past year we received 3 of these cases, one 
of which was a patient with acute leukemia showing 
some lineage infidelity in a small proportion of cells 
while most of the cells were undifferentiated. In 
two of the cases TPA-induced the appearance of 
myeloperoxidase positive blasts as seen by 
transmission electron microscopy. In the third case, 
a proportion of cells developed paranuclear acid 
phosphatase and early T-cell markers after TPA. 
Thus this methodology may have some diagnostic 
potential in acute leukemias of this nature. 
D. Soligo: Human recombinant alpha-2C interferon 
has been recently shown to have a clear antitumor 
effect on hairy cell leukemia which still has to be 
elucidated. In short term cultures alpha-2C 
interferon was shown to induce antigen modulation in 
hairy cells. Induction of class II HLA antigens was 
also described on B-cell lymphomas and macrophage 
cell lines. Do you think that cell surface 
morphological changes could be also detected and 
help in some way to understand the mechanism of 
action of interferons on B-cell malignancies ? 
Authors: We have no experience with alpha-2C 
interferon interactions with hairy cell leukemia or 
other B-cell neoplasias. However other authors have 
published striking morphological changes in both 
these disorders. One of these studies was reported 
in the recent SEM meeting by Gamliel et al. (39). It 
is indeed possible that analysis of these changes may 
help in understanding the mechanism of action of 
interferons in B-cell diseases. 
M .C. Rosner: Do the authors not feel that the 
transformation of neoplastic B-cells into hairy cells 
requires more proof than that presented in the 
manuscript? 
Authors: In this study we have been careful to use 
the terminology "hairy cell features" after exposure 
of B-CLL cells to TPA. In fact other authors have 
been more liberal in this respect and termed the 
changes seen as transformation to hairy cells. 
However, the surface changes recorded resemble 
those seen in hairy cells and the induction of TRAP+ 
cells is most impressive. The cells transformed do 
not show ribosomal lamellar complexes but have 
other ultrastructural findings encountered in hairy 
cells by transmission electron microscopy. Although 
they lack strongly staining surface immunoglobulin 
they do express other hairy cell markers detected by 
monoclonal anti Leu M-5 and TAC, regarded as 
typical for hairy cells. Indeed, these cells show 
many features of hairy cells! 
M .C. Rosner: No biochemical and surface marker 
data are available for the NHL, ANLL and HCL 
patients. Without this data are many of the claims 
made in the paper not justified? 
Authors: The general answer is no, as we have 
attempted in this report to stress the value of the 
in-vitro growth patterns in distinguishing different 
leukemias. The primary question was in fact - can 
we distinguish HCL, from other B-cell neoplasias and 
ANLL? The answer to this specific question is yes, 
we can when samples are examined by the SEM! 
Some of the surface marker data obtained in NHL 
and HCL patients has now been included in the text 
of the manuscript. Data on ANLL cells from a 
larger series of patients has been reported in an 
earlier publication (text ref. 28). 
J .S. Greenberger: Are the changes seen in the 
clumps of TPA-exposed B-CLL cells (Fig. 3) 
restricted to TPA or is this seen with exposure to 
alkylating agents (L-PAM) or other non-specific toxic 
agents? Do the cells also clump in a similar fashion 
if treated with Con A, PHA or other mitogens? 
Authors: We have not used L-PAM, alkylating agents 
or other non-specific toxic agents in our studies 
until now but we do not feel that the changes 
illustrated relate to toxicity of the TPA. Cells 
appeared to be viable when the trypan-blue exclusion 
tests were performed and light and transmission 
electron microscopy confirmed that the cells were 
viable. Toxicity with cellular damage causes a 
different surface morphology which is well 
recognized by SE M. "Clumping" is not a feature of 
PHA or PWM-transformed mononuclear cells, which 
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in general result in a different cell surface pattern 
of changes. Con-A may produce similar clumping 
without the striking changes in surface morphology 
seen in this study. 
J. S. Greenberger: The different in vitro growth 
patterns seen m B-CLL (Fig. 2) and HCL (Fig. 6) are 
striking and the cytoplasmic processes developing on 
HCL are well illustrated in Figures 7 and 8. Did the 
cellular processes contain collagen types I through V, 
Laminen or fibronectin? What is the mechanism of 
surface spreading in these cells compared to those 
shown in Figure 2? In the text, the authors indicate 
that the cells resembled fibroblasts or cultured 
macrophages and thus the question of cell attachment 
and which specific components cause attachment is 
quite relevant. 
Authors: Unfortunately, we did not study collagen, 
lam1nen or fibronectin in any of our cell suspensions 
and are thus unable to provide data on the 
biochemistry of the cell processes. We are therefore 
not in a position to comment on the molecular basis 
of surface spreading. 
J .S. Greenberger: The difference between the 
leukemic monoblast shown in Figure 12 and the hairy 
cells shown in Figure 5 is not so striking except for 
the cell size. What is the variation between 
populations of cells in each of these two groups and 
do some specimens overlap in their morphology 
between groups? 
Authors: This question is quite relevant and as a 
matter of fact in our earliest publications on hairy 
cells in 1975 we indeed suggested that they were 
closer to macrophages than lymphocytes because of 
their similar surface features as seen by SEM. Some 
overlap does occur and we and other authors 
including Gamliel and Golomb have outlined these 
features in other publications. Gamliel and Golomb 
described this in more detail in a recent review on 
HCL (38). Briefly, hairy cells generally show ruffles 
and microvilli on their surfaces with different 
combinations of these two types of microprojections 
expressed on the same cell, while monoblasts rarely 
show both these features on the same cell. Ruffles 
are the most frequent surface feature seen on 
monoblasts. 
J. S. Greenberger: The morphology of the monoblasts 
shown m Figure 14 is commonly seen with cells that 
are dying or have been exposed to serum-free 
medium, heat or poor incubator conditions with bad 
acid pH balance. What is the evidence that these 
changes are specific to TPA and not induced by 
other toxic environmental conditions? Clones such 
as those shown in Figure 15 (prominently adherent B 
cells, after 6 days culture with TPA), will often 
happen to a cellular monolayer that is sloughing from 
the surface of a plastic dish. Is this not a 
possibility here? 
Authors: Based on our extensive experience with 
SE M over the past 14 years, we do not feel that 
these features are related to sloughing, cell toxicity 
or cell death induced by toxic environmental 
conditions, or poor incubator conditions with bad 
acid pH balance. We are aware of the role 
environmental factors play in determining cell 
surface alterations but do not feel this is the case in 
our study. However, specific parallel controlled 
samples testing this hypothesis were not performed 
in these studies. 
J. S. Greenberger: The authors use the term 
"plasmacytoid transformation of cells" in the text but 
it is not clear on what basis this description is being 
given. Do the authors have some evidence of plasma 
cells that have been purified from normal bone 
marrow and are these features truly found in plasma 
cells? 
Authors: The plasmacytic features described were 
readily evident on light microscopy and in particular 
on transmission electron microscopy (TEM). Cells 
showed as eccentric nucleus with abundant basophilic 
cytoplasm and prominent rough endoplasmic reticulum 
was evident on TEM. Furthermore the induction of 
tartrate-sensitive acid phosphatase provided further 
evidence for this hypothesis while cells secreted 
immunoglobulin into the culture medium. All the 
above features are compatible with "plasmacytoid" 
transformation. These features have been described 
in our earlier publications and have been noted by 
different groups studying the effects of TPA on B-
CLL cells. 
J .S. Greenberger: Attempts to show the increase in 
the number of cells that are surface marker positive 
are depicted in Figure 19. Controls for other toxic 
agents would be of interest including heat, UV 
irradiation, exposure to alkylating agents or other 
non-tumor promoter phorbol esters. Were these 
performed at any time? 
Authors: We cannot reply readily to this interesting 
question as we have not used the above procedures 
or agents as controls in our studies. Nevertheless, 
we can state that some of the surface markers for 
B-cells such as mouse rosetting qualities tend to 
disappear during in vitro incubation of viable control 
cells unexposed to TPA. 
J .S. Greenberger: The data shown in Figures 20 and 
21 (relatmg to TPA-induced secretion in CLL cells 
and TPA-induced acid phosphatase in CLL cells) are 
more convincing evidence of induced differentiation 
by TPA. It would help to have standard error bars 
or at least the number of times the experiment was 
done, to describe the margin of significance in the 
data in these two figures. Could you comment? 
Authors: No standard error bars were determined in 
these cases, however the experiment (Fig. 20) was 
done in triplicate samples and the variations were 
less than 10%. The results depicted in Fig. 21 are 
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